Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-15-014611
Filing Date
2015-08-04
Accepted
2015-08-03 18:08:14
Documents
12
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20150630_10q.htm 10-Q 1411086
2 EXHIBIT 10.2 ex10-2.htm EX-10.2 877845
3 EXHIBIT 31.1 ex31-1.htm EX-31.1 9727
4 EXHIBIT 31.2 ex31-2.htm EX-31.2 9900
5 EXHIBIT 32.1 ex32-1.htm EX-32.1 7788
12 cover10-2.jpg GRAPHIC 283057
  Complete submission text file 0001437749-15-014611.txt   6190752

Data Files

Seq Description Document Type Size
6 EXHIBIT 101.INS acrx-20150630.xml EX-101.INS 1008324
7 EXHIBIT 101.SCH acrx-20150630.xsd EX-101.SCH 47576
8 EXHIBIT 101.CAL acrx-20150630_cal.xml EX-101.CAL 29409
9 EXHIBIT 101.DEF acrx-20150630_def.xml EX-101.DEF 196891
10 EXHIBIT 101.LAB acrx-20150630_lab.xml EX-101.LAB 277331
11 EXHIBIT 101.PRE acrx-20150630_pre.xml EX-101.PRE 192897
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 151023555
SIC: 2834 Pharmaceutical Preparations